Acquiring Company
Eli Lilly and Company
Acquired Company
CrossBridge Bio
IndianapolisHoustonManufacturingBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareTherapeuticsDescription
Eli Lilly and Company has entered into a definitive agreement to acquire CrossBridge Bio, Inc., a biotechnology firm focused on dual-payload antibody-drug conjugates. The transaction could total up to $300 million, depending on development milestones. This acquisition will advance Lilly's capabilities in cancer therapeutics, particularly with CrossBridge's lead candidate, CBB-120. The deal is expected to strengthen efforts in improving patient treatment options.
Quick answer
Eli Lilly and Company is acquiring CrossBridge Bio, announced April 14, 2026. Eli Lilly and Company is based in Indianapolis, Indiana, United States.
- How much did Eli Lilly and Company pay for CrossBridge Bio?
- The deal value was not disclosed.
- What does Eli Lilly and Company do?
- Lilly is a medicine company turning science into healing to make life better for people around the world.
- Where are Eli Lilly and Company and CrossBridge Bio based?
- Eli Lilly and Company is based in Indianapolis, Indiana, United States. CrossBridge Bio is based in Houston, Texas, United States.
- Who are the decision-makers at Eli Lilly and Company?
- Fundz holds 5 contacts at Eli Lilly and Company. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- ESTEVE acquires TerSera's Infusion Business Unit (May 4, 2026)
- Eli Lilly to acquire Ajax Therapeutics for $2.3B, $2.3B (April 27, 2026)
- Eli Lilly to acquire Centessa Pharmaceuticals (March 31, 2026)
- Eli Lilly acquires Engage Bio to enhance genetic medicines (May 20, 2026)
- Gilead Sciences to acquire MacroGenics for $1.7B, $1.7B (May 19, 2026)
- Lupin completes acquisition of VISUfarma (April 2, 2026)
Who to call at Eli Lilly and Company, and when
When Eli Lilly and Company changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Eli Lilly and Company raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eli Lilly and Company, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eli Lilly and Company. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eli Lilly and Company makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired CrossBridge Bio?
CrossBridge Bio was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on April 14, 2026. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is publicly traded (LLY) and operates in Manufacturing.
When did Eli Lilly and Company acquire CrossBridge Bio?
Eli Lilly and Company's acquisition of CrossBridge Bio was reported on April 14, 2026. Eli Lilly and Company has entered into a definitive agreement to acquire CrossBridge Bio, Inc., a biotechnology firm focused on dual-payload antibody-drug conjugates. The transaction could total up to $300 million, depending on development milestones. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does CrossBridge Bio do?
CrossBridge Bio is pioneering an approach to deliver the next generation of stable antibody-drug conjugates (ADC) therapeutics that carry dual payloads as targeted treatments for a range of challenging cancers. Leveraging technology from the labs of Dr. It is privately held, operating in Biotechnology, and is based in Houston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.